Migration, invasion, and colony formation assay data clearly demonstrate that FOXC1 is an oncogenic TF, which could be a potential therapeutic target to inhibit metastatic capabilities of pancreatic cancers. This evidence concerns the gene TF and pancreatic neoplasm.